دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 0
نویسندگان: Archie W. Prestayko (Eds.)
سری:
ISBN (شابک) : 9780125650502, 0125650507
ناشر: Academic Press Inc
سال نشر: 1980
تعداد صفحات: 519
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 21 مگابایت
در صورت تبدیل فایل کتاب Cisplatin. Current Status and New Developments به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب سیس پلاتین وضعیت فعلی و تحولات جدید نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
این جلد دیدگاهی تاریخی در مورد توسعه میتومایسین C ارائه میکند، پیشرفتهای اخیر، از جمله مطالعات روی آنالوگها را خلاصه میکند، و جهتهای جدیدی را برای تحقیقات آینده پیشنهاد میکند.
This volume provides a historical perspective on the development of mitomycin C, summarizes recent developments, including studies on analogs, and suggests new directions for future research
Content:
Front Matter, Page i
Copyright, Page ii
CONTRIBUTORS, Pages vii-xiv
PREFACE, Page xv
Chapter 1 - CISPLATIN: A PRECLINICAL OVERVIEW, Pages 1-7, Archie W. Prestayko
Chapter 2 - CISPLATIN: ITS HISTORY AND POSSIBLE MECHANISMS OF ACTION, Pages 9-20, Barnett Rosenberg
Chapter 3 - EFFECTS OF CISPLATIN ON DNA AND THE POSSIBLE RELATIONSHIPS TO CYTOTOXICITY AND MUTAGENICITY IN MAMMALIAN CELLS, Pages 21-35, Leonard A. Zwelling, Kurt W. Kohn
Chapter 4 - THE LETHAL ACTIVITY OF PLATINUM COMPOUNDS IN COMBINATION WITH PYRIMIDINE DERIVATIVES, Pages 37-55, Benjamin Drewinko, Peter Corry, John-Pierre Bergerat, Barthel Barlogie
Chapter 5 - REPAIR OF cis-PLATINUM (II) DIAMMINE DICHLORIDE-INDUCED DNA DAMAGE AND CELL SENSITIVITY, Pages 57-77, John J. Roberts, Hadrian N.A. Fraval
Chapter 6 - ULTRASTRUCTURAL EFFECTS OF CISPLATIN, Pages 79-111, Surinder K. Aggarwal, Michael W. Whitehouse, C. Ramachandran
Chapter 7 - RATIONALE OF COMBINATION CHEMOTHERAPY, Pages 113-123, Joseph H. Burchenal, Linda Lokys, John Turkevich, Glen Gale
Chapter 8 - A REVIEW OF INTERACTIONS BETWEEN PLATINUM COORDINATION COMPLEXES AND IONIZING RADIATION: IMPLICATIONS FOR CANCER THERAPY, Pages 125-147, Evan B. Douple, Robert C. Richmond
Chapter 9 - ANTITUMOR PLATINUM COMPLEXES: STRUCTURE-ACTIVITY RELATIONSHIPS, Pages 149-170, Michael J. Cleare, Paul C. Hydes, Deric R. Hepburn, Bernard W. Malerbi
Chapter 10 - ANTITUMOR ACTIVITY OF PLATINUM ANALOGS, Pages 171-182, William T. Bradner, William C. Rose, James B. Huftalen
Chapter 11 - ANTITUMOR ACTIVITY OF CISPLATIN ANALOGS, Pages 183-191, Mary K. Wolpert-DeFilippes
Chapter 12 - ANTITUMOR, TOXIC AND BIOCHEMICAL PROPERTIES OF CISPLATIN AND EIGHT OTHER PLATINUM COMPLEXES, Pages 193-212, Kenneth R. Harrap, Mervyn Jones, C. Ray Wilkinson, Hugh McD. Clink, Stephen Sparrow, Bernard C.V. Mitchley, Sylvia Clarke, Ann Veasey
Chapter 13 - IN VITRO INTERACTION OF COVALENTLY LINKED CLOSED CIRCULAR DNA WITH THE SECOND-GENERATION PLATINUM COMPOUNDS, Pages 213-226, Seymour Mong, Archie W. Prestayko, Stanley T. Crooke
Chapter 14 - TOXIC SIDE EFFECTS OF PLATINUM ANALOGS, Pages 227-236, John E. Schurig, William T. Bradner, James B. Huftalen, Gary J. Doyle, Jonas A. Gylys
Chapter 15 - APPROACHES TO STUDIES OF PLATINATE TOXICITIES, Pages 237-248, Anthony M. Guarino, David S. Miller, Susan T. Arnold, Mary A. Urbanek, Mary K. Wolpert-DeFilippes, Miles P. Hacker
Chapter 16 - MORPHOLOGICAL MANIFESTATIONS OF CISPLATIN ANALOGS IN RATS: AN ULTRASTRUCTURAL STUDY, Pages 249-269, Yerach Daskal, Archie W. Prestayko, Stanley T. Crooke
Chapter 17 - RADIOPHARMACOKINETICS OF CISPLATIN, Pages 271-283, Randall C. Manaka, Walter Wolf
Chapter 18 - REACTIONS OF CISPLATIN WITH HUMAN PLASMA AND PLASMA FRACTIONS, Pages 285-304, Arnold J. Repta, David F. Long
Chapter 19 - PHYSICAL COMPATIBILITY AND CHEMICAL STABILITY OF CISPLATIN IN VARIOUS DILUENTS AND IN LARGE-VOLUME PARENTERAL SOLUTIONS, Pages 305-316, Elio P. Mariani, Bruce J. Southard, John T. Woolever, Ronald H. Erlich, Alphonse P. Granatek
Chapter 20 - CISPLATIN: A CLINICAL OVERVIEW, Pages 317-321, John R. Durant
Chapter 21 - CISPLATIN CHEMOTHERAPY OF TESTICULAR CANCER, Pages 323-328, Stephen D. Williams, Lawrence H. Einhorn
Chapter 22 - SEQUENTIAL COMBINATION CHEMOTHERAPY WITH VINBLASTINE-BLEOMYCIN AND ADRIAMYCIN-CISPLATIN IN EARLY AND LATE TESTICULAR CANCER, Pages 329-344, Siegfried Seeber, Max E. Scheulen, Rudolf B. Schilcher, Markus Higi, Norbert Niederle, Despina Mouratidou, Werner C. Bierbaum, Carl G. Schmidt
Chapter 23 - CISPLATIN ANALOGS AND COMBINATION CHEMOTHERAPY IN THE THERAPY OF MURINE BLADDER CANCER, Pages 345-359, Mark S. Soloway, Steven B. Masters, William M. Murphy
Chapter 24 - CISPLATIN REGIMENS IN THE TREATMENT OF BLADDER AND PENILE CANCER, Pages 361-374, Alan Yagoda
Chapter 25 - TREATMENT OF ADVANCED ADENOCARCINOMA OF THE PROSTATE WITH CISPLATIN, Pages 375-381, Claude Merrin
Chapter 26 - CISPLATIN THERAPY OF OVARIAN CANCER, Pages 383-391, James F. Holland, Howard W. Bruckner, Carmel J. Cohen, Robert C. Wallach, Saul B. Gusberg, Ezra M. Greenspan, Judith Goldberg
Chapter 27 - CISPLATIN COMBINATION CHEMOTHERAPY FOR DRUG-RESISTANT OVARIAN CARCINOMA, Pages 393-401, David S. Alberts, Robert D. Hilgers, Thomas E. Moon, Robert O'Toole, Frank Mantz, Pierre W. Martimbeau, Ronald L. Stephens, Saul Rivkin, Nancy Mason
Chapter 28 - CISPLATIN IN TREATMENT OF CERVICAL AND ENDOMETRIAL CANCER PATIENTS, Pages 403-409, Laurence H. Baker
Chapter 29 - CISPLATIN IN THE TREATMENT OF ADVANCED OR RECURRENT CERVIX AND UTERINE CANCER, Pages 411-421, J. Tate Thigpen, Hugh Shingleton, Howard Homesley, Philip DiSaia, Leo Lagasse, John Blessing
Chapter 30 - THE ROLE OF CISPLATIN IN THE TREATMENT OF RECURRENT HEAD AND NECK CANCER, Pages 423-430, Charlotte Jacobs
Chapter 31 - INDUCTION CHEMOTHERAPY OF ADVANCED PREVIOUSLY UNTREATED SQUAMOUS CELL HEAD AND NECK CANCER WITH CISPLATIN AND BLEOMYCIN, Pages 431-444, Waun Ki Hong, Rakesh Bhutani, Stanley M. Shapshay, Stuart Strong
Chapter 32 - CLINICAL RESULTS WITH CISPLATIN IN LUNG CANCER, Pages 445-458, Daniel D. Von Hoff, David Elson
Chapter 33 - THE USE OF INTRAVENOUS CISPLATIN IN VARIOUS ADULT MALIGNANCIES, Pages 459-464, Michael A. Friedman
Chapter 34 - CISPLATIN IN METASTATIC OSTEOGENIC SARCOMA, Pages 465-475, Gerald Rosen, Anita Nirenberg, Brenda Caparros, Herbert Juergens, Charlotte Tan, Manuel Gutierrez
Chapter 35 - PHASE II EVALUATION OF CISPLATIN IN CHILDREN WITH NEUROBLASTOMA AND OTHER MALIGNANT SOLID TUMORS, Pages 477-484, Alexander A. Green, F. Ann Hayes, Charles B. Pratt, William E. Evans, Cathryn B. Howarth, Neil Senzer
Chapter 36 - CISPLATIN NEPHROTOXICITY: THE EFFECT OF DOSE, SCHEDULE, AND HYDRATION SCHEME, Pages 485-494, Robert L. Comis
Chapter 37 - TREATMENT OF REGIONALLY CONFINED METASTATIC TUMORS WITH ARTERIAL INFUSION OF CISPLATIN, Pages 495-509, Yehuda Z. Patt, Dionisio B. Calvo III, Robert S. Benjamin, Giora M. Mavligit
Chapter 38 - DESIGN OF CLINICAL TRIALS WITH CISPLATIN ANALOGS, Pages 511-516, Stephen K. Carter
Chapter 39 - CLINICAL RESULTS WITH CISPLATIN ANALOGS, Pages 517-527, Franco M. Muggia, Mary K. Wolpert-DeFilippes, Patricia Ribaud, Georges Mathé